Anavex Life Sciences Corp (AVXL)

[wildcard235]

I've been long on AVXL since 2011, although I bought most of my shares in February 2015, with the lowest cost at 16 cents/share (pre-reverse-split).

I agree with just about everything you said except I will add that the risk is now significantly reduced by having multiple trials targeting multiple indications. Insufficient results in one will not be nearly as bad as it would be if we only had one trial in progress.